tiprankstipranks
Exelixis price target lowered to $21 from $22 at Morgan Stanley
The Fly

Exelixis price target lowered to $21 from $22 at Morgan Stanley

Morgan Stanley analyst Jeffrey Hung lowered the firm’s price target on Exelixis to $21 from $22 and keeps an Equal Weight rating on the shares. The firm issued its biotechnology Q1 sector preview, stating that broadly for the group it does not "expect many surprises" given recently issued guidance. The firm sees investor focus being mainly on Q2 catalysts in the space.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on EXEL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles